vor 6 Jahren

Paion-Aktie: Aufbau des Vertriebs wird belasten

Wer hoffte, dass die Spezialpharmafirma Paion mit der Zulassung des Narkosemittels Byfavo in vielen Regionen nun Royaltys kassieren kann, sieht sich getäuscht. Von Jörg Lang

Quelle: Börse Online RSS Feed

Narrowing the time-risk-cost gap.vor 2 Stunden
This guy was mining 1 Bitcoin every day in 2011. He built an $800 gaming PC, downloaded the mining software, ran it 24/7, and was earning Bitcoin like it was nothing. A true legend from the early days of Bitcoinvor 7 Stunden
Bitcoin been chopping all day but that feeling is backvor 8 Stunden
The Trap is Setvor 9 Stunden
Could Something like Executive Order 6102 Happen to BTC?vor 9 Stunden
Will Bitcoin cash ever have Wrapped Bitcoin on its blockchain?vor 10 Stunden
The CLARITY Act Has One Last Chance Before Crypto Rules Could Be Delayed for Yearsvor 10 Stunden
Whatever Happened to “Bitcoin, Not Bombs”vor 11 Stunden
Graph Magicians Back At It Againvor 11 Stunden
iPhone VS Bitcoinvor 11 Stunden